SecBot SecBot

YDES

YD Bio Ltd
Nasdaq· Services-Medical Laboratories· Inc. E9· CIK 0002011674 Healthcare & Medical Devices
$6.04 +0.75 (+14.18%)
Oct 27 4:00 PM ET · prev $5.29
Market cap
$350.6M
Small cap
1 year
−61.8%
from $15.80 · Oct 28
30 days
−15.0%
from $7.11
52-week range
$1.90–15.80
−62% from high · low Jul 2
Avg volume 20D
171.3K
Oct 2 spike 546.6K
Short interest
192.2K
≈0.3% of shares · +8.4%
Days to cover
1.0
at average volume
Insider net
+$128.5K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
3
analyzed by SecBot
SecBot read BEARISH 2 reports · 90 days
Balance 1 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score
Strongest BEARISH YD Bio reported financial results for the six months ended June 30, 2026, showing headline net income of…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $128.5K at an average $3.76. No open-market sales. Price is 61% above their cost.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 1 trimmed or exited.

  • Short sellersSTEADY

    Short interest +8.4% to 192.2K shares. 1.0 days to cover, ≈0.3% of shares.

  • TrendUPTREND

    20% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
CITADEL ADVISORS LLCADD30,106$67.7K
MORGAN STANLEYTRIM160$360.00

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 23, 2026
Earnings date
YDES Q2 2026 Earnings Scheduled — 2026-09-23
Aug 31, 2026
Earnings
YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026
TAIPEI, Taiwan, Aug. 31, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA…
Aug 31, 2026
Trading halt
Halt Resumed: YDES — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-08-31T15:28:37.000Z | Resumed 2026-08-31T15:43:30.000Z
Aug 31, 2026
Trading halt
Trading Halt: YDES — LUDP (Volatility Trading Pause)
YD Bio Limited Ordinary Shares | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Aug 28, 2026
Trading halt
Halt Resumed: YDES — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-08-28T19:43:41.000Z | Resumed 2026-08-28T20:00:00.000Z

Insider ledger

Form 4
$128.5K
bought · 1 insider
$0
sold · 0 insiders
+60.6%
vs their $3.76 cost
DateInsiderTypeValue
Sep 30, 2026
Chang Kochi
Director
EXERCISE3,135 sh
Sep 30, 2026
Lu Shao-Ta
Director
EXERCISE3,135 sh
Sep 30, 2026
Chang Kochi
Director
AWARD3,135 sh
Sep 30, 2026
Lu Shao-Ta
Director
AWARD3,135 sh
Sep 14, 2026
Shen Ethan PhD
CEO
BUY$48.9K
Sep 9, 2026
Shen Ethan PhD
CEO
BUY$12.2K
Sep 4, 2026
Shen Ethan PhD
CEO
BUY$67.4K
Jun 30, 2026
Chang Kochi
Director
EXERCISE5,749 sh

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
192,222
shares short
+8.4%
vs prior settlement
1.0
days to cover
≈0.3%
of shares outstanding
Trading halts
Aug 31, 2026Volatility PauseResumed
Aug 28, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 Insider
Chang Kochi acquired via exercise 3,135 shares
Director
Sep 30, 2026 Insider
Lu Shao-Ta acquired via exercise 3,135 shares
Director
Sep 30, 2026 Insider
Chang Kochi was granted 3,135 shares
Director
Sep 23, 2026 Earnings calendar
YDES Q2 2026 Earnings Scheduled — 2026-09-23
Aug 31, 2026 SEC
YD Bio reported financial results for the six months ended June 30, 2026, showing headline net income of $6.7M (vs a…
PRESS-RELEASE — Impact 6/10
Aug 11, 2026 SEC
YD Bio announced the launch of two nutraceutical products in Taiwan under a new physician-partnership model…
6-K — Impact 3/10
Jun 30, 2026 Inst.
CITADEL ADVISORS LLC — ADD
30,106 shares ($67.7K)
Jun 30, 2026 Inst.
MORGAN STANLEY — TRIM
160 shares ($360.00)

SecBot reports

3 filings · 0 bullish · 2 bearish · 1 neutral
All YDES filing & press-release reports (3)